Piramal Enterprises’ arm enters into agreement with G&W Laboratories
20th Jun 2020

Piramal Enterprises’ pharma solutions business, a leading Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.

According to the terms of the agreement, the company, through one of its Affiliates, would acquire at closing a 100% stake in G&W PA Laboratories LLC (G&W PA) in an all-cash deal for a total consideration of $17.5 million. This acquisition broadens the offering of Piramal Pharma Solutions (PPS) by adding solid oral dosage form capabilities (tablets and capsules) in North America.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.